Epigenomic Profiling Reveals DNA-Methylation Changes Associated with Major Psychosis

American Journal of Human Genetics

Volumn 82, Issue 3, 2008, Pages 696-711

  Mill, Jonathan ^a,b   Tang, Thomas ^a   Kaminsky, Zachary ^a   Khare, Tarang ^a   Yazdanpanah, Simin ^a   Bouchard, Luigi ^a,c   Jia, Peixin ^a   Assadzadeh, Abbas ^a   Flanagan, James ^a,d   Schumacher, Axel ^a,e   Wang, Sun Chong ^a,f   Petronis, Arturas ^a  

^a CENTRE FOR ADDICTION AND MENTAL HEALTH   (Canada)

^b KING'S COLLEGE LONDON   (United Kingdom)

^c LAVAL UNIVERSITY   (Canada)

^d UNIVERSITY COLLEGE LONDON   (United Kingdom)

^e TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^f NATIONAL CENTRAL UNIVERSITY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

BRAIN DERIVED NEUROTROPHIC FACTOR; MITOGEN ACTIVATED PROTEIN KINASE KINASE 1;

ADULT; ARTICLE; BIPOLAR DISORDER; BRAIN DEVELOPMENT; CLINICAL FEATURE; CONTROLLED STUDY; DEMOGRAPHY; DISEASE ASSOCIATION; DNA METHYLATION; EPIGENETICS; FEMALE; GENE LOCUS; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; MICROARRAY ANALYSIS; PRIORITY JOURNAL; SCHIZOPHRENIA; SINGLE NUCLEOTIDE POLYMORPHISM; BRAIN; CPG ISLAND; DNA MICROARRAY; GENE; GENETIC EPIGENESIS; GENETICS; METABOLISM; MIDDLE AGED; MOLECULAR GENETICS; NUCLEOTIDE SEQUENCE;

ADULT; BASE SEQUENCE; BIPOLAR DISORDER; BRAIN; CPG ISLANDS; DNA METHYLATION; EPIGENESIS, GENETIC; FEMALE; GENES; HUMANS; MALE; MIDDLE AGED; MOLECULAR SEQUENCE DATA; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; SCHIZOPHRENIA;

EID: 41149140859     PISSN: 00029297     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ajhg.2008.01.008     Document Type: Article

References (63)

1. Craddock N., O'Donovan M.C., and Owen M.J. Genes for schizophrenia and bipolar disorder? Implications for psychiatric nosology. Schizophr. Bull. 32 (2006) 9-16
2. Craddock N., O'Donovan M.C., and Owen M.J. The genetics of schizophrenia and bipolar disorder: dissecting psychosis. J. Med. Genet. 42 (2005) 193-204
3. Petronis A. The origin of schizophrenia: genetic thesis, epigenetic antithesis, and resolving synthesis. Biol Psychiatry 55 (2004) 965-970
4. Craddock N., and Jones I. Genetics of bipolar disorder. J. Med. Genet. 36 (1999) 585-594
5. McGuffin P., Asherson P., Owen M., and Farmer A. The strength of the genetic effect. Is there room for an environmental influence in the aetiology of schizophrenia?. Br. J. Psychiatry 164 (1994) 593-599
6. Henikoff S., and Matzke M.A. Exploring and explaining epigenetic effects. Trends Genet. 13 (1997) 293-295
7. Riggs A.D., Xiong Z., Wang L., and LeBon J.M. Methylation dynamics, epigenetic fidelity and X chromosome structure. Novartis Found. Symp. 214 (1998) 214-225
8. Richards E.J. Inherited epigenetic variation-revisiting soft inheritance. Nat. Rev. Genet. 7 (2006) 395-401
9. Abdolmaleky H.M., Cheng K.H., Faraone S.V., Wilcox M., Glatt S.J., Gao F., Smith C.L., Shafa R., Aeali B., Carnevale J., et al. Hypomethylation of MB-COMT promoter is a major risk factor for schizophrenia and bipolar disorder. Hum. Mol. Genet. 15 (2006) 3132-3145
10. Grayson D.R., Jia X., Chen Y., Sharma R.P., Mitchell C.P., Guidotti A., and Costa E. Reelin promoter hypermethylation in schizophrenia. Proc. Natl. Acad. Sci. USA 102 (2005) 9341-9346
11. Tochigi M., Iwamoto K., Bundo M., Komori B., Sasaki T., Kato N., and Kato T. Methylation status of the reelin promoter region in the brain of schizophrenic patients. Biol. Psychiatry 63 (2008) 530-533
12. Dempster E.L., Mill J., Craig I.W., and Collier D.A. The quantification of COMT mRNA in post mortem cerebellum tissue: diagnosis, genotype, methylation and expression. BMC Med. Genet. 7 (2006) 10
13. Johnston-Wilson N.L., Sims C.D., Hofmann J.P., Anderson L., Shore A.D., Torrey E.F., and Yolken R.H. Disease-specific alterations in frontal cortex brain proteins in schizophrenia, bipolar disorder, and major depressive disorder. The Stanley Neuropathology Consortium. Mol. Psychiatry 5 (2000) 142-149
14. Schumacher A., Kapranov P., Kaminsky Z., Flanagan J., Assadzadeh A., Yau P., Virtanen C., Winegarden N., Cheng J., Gingeras T., et al. Microarray-based DNA methylation profiling: technology and applications. Nucleic Acids Res. 34 (2006) 528-542
15. Benjamini Y., and Hochberg Y. Controlling the false discovery rate: a practical and powerful approach to multiple testing. J. Roy. Statist. Soc. Ser. B. Methodological 57 (1995) 289-300
16. Craddock N., and Owen M.J. Rethinking psychosis: the disadvantages of a dichotomous classification now outweigh the advantages. World Psychiatry 6 (2007) 20-27
17. Newman M.E. Modularity and community structure in networks. Proc. Natl. Acad. Sci. USA 103 (2006) 8577-8582
18. Schafer J., and Strimmer K. A shrinkage approach to large-scale covariance matrix estimation and implications for functional genomics. Stat. Appl. Genet. Mol. Biol. 4 (2005) Article32
19. Mann H., Ben-Asouli Y., Schein A., Moussa S., and Jarrous N. Eukaryotic RNase P: role of RNA and protein subunits of a primordial catalytic ribonucleoprotein in RNA-based catalysis. Mol. Cell 12 (2003) 925-935
20. Westhoff C.M., and Reid M.E. Review: the Kell, Duffy, and Kidd blood group systems. Immunohematol. 20 (2004) 37-49
21. Higgs B.W., Elashoff M., Richman S., and Barci B. An online database for brain disease research. BMC Genomics 7 (2006) 70
22. Klempnauer K.H. Methylation-sensitive DNA binding by v-myb and c-myb proteins. Oncogene 8 (1993) 111-115
23. Maier H., Colbert J., Fitzsimmons D., Clark D.R., and Hagman J. Activation of the early B-cell-specific mb-1 (Ig-alpha) gene by Pax-5 is dependent on an unmethylated Ets binding site. Mol. Cell. Biol. 23 (2003) 1946-1960
24. Cowled P., Kanter I., Leonardos L., and Jackson P. Uroplakin Ib gene transcription in urothelial tumor cells is regulated by CpG methylation. Neoplasia 7 (2005) 1091-1103
25. Prabakaran S., Swatton J.E., Ryan M.M., Huffaker S.J., Huang J.T., Griffin J.L., Wayland M., Freeman T., Dudbridge F., Lilley K.S., et al. Mitochondrial dysfunction in schizophrenia: evidence for compromised brain metabolism and oxidative stress. Mol Psychiatry 9 (2004) 684-697 643
26. Coyle J.T. The GABA-glutamate connection in schizophrenia: which is the proximate cause?. Biochem. Pharmacol. 68 (2004) 1507-1514
27. Benes F.M., and Berretta S. GABAergic interneurons: implications for understanding schizophrenia and bipolar disorder. Neuropsychopharmacology 25 (2001) 1-27
28. Lau C.G., and Zukin R.S. NMDA receptor trafficking in synaptic plasticity and neuropsychiatric disorders. Nat. Rev. Neurosci. 8 (2007) 413-426
29. Gupta D.S., McCullumsmith R.E., Beneyto M., Haroutunian V., Davis K.L., and Meador-Woodruff J.H. Metabotropic glutamate receptor protein expression in the prefrontal cortex and striatum in schizophrenia. Synapse 57 (2005) 123-131
30. Fremeau Jr. R.T., Troyer M.D., Pahner I., Nygaard G.O., Tran C.H., Reimer R.J., Bellocchio E.E., Fortin D., Storm-Mathisen J., and Edwards R.H. The expression of vesicular glutamate transporters defines two classes of excitatory synapse. Neuron 31 (2001) 247-260
31. Eastwood S.L., and Harrison P.J. Decreased expression of vesicular glutamate transporter 1 and complexin II mRNAs in schizophrenia: further evidence for a synaptic pathology affecting glutamate neurons. Schizophr. Res. 73 (2005) 159-172
32. Smith R.E., Haroutunian V., Davis K.L., and Meador-Woodruff J.H. Vesicular glutamate transporter transcript expression in the thalamus in schizophrenia. Neuroreport 12 (2001) 2885-2887
33. Bruneau E.G., McCullumsmith R.E., Haroutunian V., Davis K.L., and Meador-Woodruff J.H. Increased expression of glutaminase and glutamine synthetase mRNA in the thalamus in schizophrenia. Schizophr. Res. 75 (2005) 27-34
34. Marksteiner J., Weiss U., Weis C., Laslop A., Fischer-Colbrie R., Humpel C., Feldon J., and Fleischhacker W.W. Differential regulation of chromogranin A, chromogranin B and secretogranin II in rat brain by phencyclidine treatment. Neuroscience 104 (2001) 325-333
35. McQuillin A., Rizig M., and Gurling H.M. A microarray gene expression study of the molecular pharmacology of lithium carbonate on mouse brain mRNA to understand the neurobiology of mood stabilization and treatment of bipolar affective disorder. Pharmacogenet. Genomics 17 (2007) 605-617
36. Couve A., Restituito S., Brandon J.M., Charles K.J., Bawagan H., Freeman K.B., Pangalos M.N., Calver A.R., and Moss S.J. Marlin-1, a novel RNA-binding protein associates with GABA receptors. J. Biol. Chem. 279 (2004) 13934-13943
37. Koyrakh L., Lujan R., Colon J., Karschin C., Kurachi Y., Karschin A., and Wickman K. Molecular and cellular diversity of neuronal G-protein-gated potassium channels. J. Neurosci. 25 (2005) 11468-11478
38. Nakatani T., Minaki Y., Kumai M., and Ono Y. Helt determines GABAergic over glutamatergic neuronal fate by repressing Ngn genes in the developing mesencephalon. Development 134 (2007) 2783-2793
39. Miyaoka T., Seno H., and Ishino H. Increased expression of Wnt-1 in schizophrenic brains. Schizophr. Res. 38 (1999) 1-6
40. Xing G., Zhang L., Russell S., and Post R. Reduction of dopamine-related transcription factors Nurr1 and NGFI-B in the prefrontal cortex in schizophrenia and bipolar disorders. Schizophr. Res. 84 (2006) 36-56
41. Kontkanen O., Lakso M., Wong G., and Castren E. Chronic antipsychotic drug treatment induces long-lasting expression of fos and jun family genes and activator protein 1 complex in the rat prefrontal cortex. Neuropsychopharmacology 27 (2002) 152-162
42. Paylor R., Zhao Y., Libbey M., Westphal H., and Crawley J.N. Learning impairments and motor dysfunctions in adult Lhx5-deficient mice displaying hippocampal disorganization. Physiol. Behav. 73 (2001) 781-792
43. Horrobin D.F., Glen A.I., and Vaddadi K. The membrane hypothesis of schizophrenia. Schizophr. Res. 13 (1994) 195-207
44. Toulouse A., Rochefort D., Roussel J., Joober R., and Rouleau G.A. Molecular cloning and characterization of human RAI1, a gene associated with schizophrenia. Genomics 82 (2003) 162-171
45. Kalscheuer V.M., FitzPatrick D., Tommerup N., Bugge M., Niebuhr E., Neumann L.M., Tzschach A., Shoichet S.A., Menzel C., Erdogan F., et al. Mutations in autism susceptibility candidate 2 (AUTS2) in patients with mental retardation. Hum. Genet. 121 (2007) 501-509
46. Hafner H. Gender differences in schizophrenia. Psychoneuroendocrinology 28 Suppl 2 (2003) 17-54
47. Arnold L.M. Gender differences in bipolar disorder. Psychiatr. Clin. North Am. 26 (2003) 595-620
48. Kaminsky Z., Wang S.C., and Petronis A. Complex disease, gender and epigenetics. Ann. Med. 38 (2006) 530-544
49. Saluz H.P., Jiricny J., and Jost J.P. Genomic sequencing reveals a positive correlation between the kinetics of strand-specific DNA demethylation of the overlapping estradiol/glucocorticoid-receptor binding sites and the rate of avian vitellogenin mRNA synthesis. Proc. Natl. Acad. Sci. USA 83 (1986) 7167-7171
50. Yokomori N., Moore R., and Negishi M. Sexually dimorphic DNA demethylation in the promoter of the Slp (sex-limited protein) gene in mouse liver. Proc. Natl. Acad. Sci. USA 92 (1995) 1302-1306
51. Jung H.H., and Haker H. Schizophrenia as a manifestation of X-linked Mcleod-Neuroacanthocytosis syndrome. J. Clin. Psychiatry 65 (2004) 722-723
52. Browning J.L., Patel T., Brandt P.C., Young K.A., Holcomb L.A., and Hicks P.B. Clozapine and the mitogen-activated protein kinase signal transduction pathway: implications for antipsychotic actions. Biol. Psychiatry 57 (2005) 617-623
53. Ashburner M., Ball C.A., Blake J.A., Botstein D., Butler H., Cherry J.M., Davis A.P., Dolinski K., Dwight S.S., Eppig J.T., et al. Gene ontology: tool for the unification of biology. The Gene Ontology Consortium. Nat. Genet. 25 (2000) 25-29
54. Ravasz E., Somera A.L., Mongru D.A., Oltvai Z.N., and Barabasi A.L. Hierarchical organization of modularity in metabolic networks. Science 297 (2002) 1551-1555
55. Rives A.W., and Galitski T. Modular organization of cellular networks. Proc. Natl. Acad. Sci. USA 100 (2003) 1128-1133
56. Spirin V., and Mirny L.A. Protein complexes and functional modules in molecular networks. Proc. Natl. Acad. Sci. USA 100 (2003) 12123-12128
57. Frigola J., Song J., Stirzaker C., Hinshelwood R.A., Peinado M.A., and Clark S.J. Epigenetic remodeling in colorectal cancer results in coordinate gene suppression across an entire chromosome band. Nat. Genet. 38 (2006) 540-549
58. Abdolmaleky H.M., Cheng K.H., Russo A., Smith C.L., Faraone S.V., Wilcox M., Shafa R., Glatt S.J., Nguyen G., Ponte J.F., et al. Hypermethylation of the reelin (RELN) promoter in the brain of schizophrenic patients: a preliminary report. Am. J. Med. Genet. B. Neuropsychiatr. Genet. 134 (2005) 60-66
59. Flanagan J.M., Popendikyte V., Pozdniakovaite N., Sobolev M., Assadzadeh A., Schumacher A., Zangeneh M., Lau L., Virtanen C., Wang S.C., et al. Intra- and interindividual epigenetic variation in human germ cells. Am. J. Hum. Genet. 79 (2006) 67-84
60. Murrell A., Heeson S., Cooper W.N., Douglas E., Apostolidou S., Moore G.E., Maher E.R., and Reik W. An association between variants in the IGF2 gene and Beckwith-Wiedemann syndrome: interaction between genotype and epigenotype. Hum. Mol. Genet. 13 (2004) 247-255
61. Veldic M., Guidotti A., Maloku E., Davis J.M., and Costa E. In psychosis, cortical interneurons overexpress DNA-methyltransferase 1. Proc. Natl. Acad. Sci. USA 102 (2005) 2152-2157
62. Weber M., Davies J.J., Wittig D., Oakeley E.J., Haase M., Lam W.L., and Schubeler D. Chromosome-wide and promoter-specific analyses identify sites of differential DNA methylation in normal and transformed human cells. Nat. Genet. 37 (2005) 853-862
63. Suter C.M., Martin D.I., and Ward R.L. Germline epimutation of MLH1 in individuals with multiple cancers. Nat. Genet. 36 (2004) 497-501